Evidence map›Paper›PMID 31684007›Full record

ArticleJournal of clinical medicine2019

Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study.

Patricia Udaondo, Cristina Hernández, Laura Briansó-Llort, Salvador García-Delpech, Olga Simó-Servat, Rafael Simó

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Neuroprotection in Diabetes Retinal Disease: An Unmet Medical Need.International journal of molecular sciences · 2026
    Review
  4. Intravitreal Fluocinolone Acetonide Implant for Diabetic Macular Edema: 2-Year Results from IDEAL, a Prospective German Observational Study.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2026
    Observational
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Liquid Biopsy Proteomics in Ophthalmology.Journal of proteome research · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Patricia UdaondoDepartment of Ophthalmology, Hospital Universitari i Politècnic La Fe, 46009 Valencia, Spain. patyudaondo@hotmail.com.
Cristina HernándezDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain. cristina.hernandez@vhir.org.ORCID 0000-0002-3109-1721
Laura Briansó-LlortDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain. laura.brianso@vhir.org.
Salvador García-DelpechDepartment of Ophthalmology, Hospital Universitari i Politècnic La Fe, 46009 Valencia, Spain. salvadorgarciadelpech@gmail.com.
Olga Simó-ServatDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain. olga.simo@vhir.org.
Rafael SimóDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain. rafael.simo@vhir.org.ORCID 0000-0003-0475-3096
Universitat Autònoma de Barcelona · ESHospital Universitari i Politècnic La Fe · ES

Funding

F. Hoffmann-La Roche VHIR-2018Instituto de Salud Carlos III PI16/00541
6 · The paper itself

Abstract

The objective was to investigate the usefulness of the "liquid biopsy" of aqueous humor (AH) to predict the clinical response after intravitreal injections (IVT) of anti-VEGF agents for treating diabetic macular edema (DME). For this purpose, AH samples obtained during the first anti-VEGF IVT from 31 type two diabetic patients were analyzed. Patients were classified into three groups according to their anti-VEGF response: rapid responders (

Indexed as

anti-VEGF agentsaqueous humorbiomarkersdiabetic macular edemainflammationpersonalized medicineVEGF

Identifiers

PMID31684007
PMCPMC6912573
OpenAlexW2985331317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.